Helixion Clinical operates exclusively in Azerbaijan and Georgia, providing local intelligence, feasibility insights, and full-cycle site support.
A fast-growing clinical research market with:
New modernised clinical trial legislation
Regulatory alignment with European principles
Over 10 million population for high enrolment potential
Large tertiary hospitals and specialised centers
Azerbaijan offers scalability and patient access across a wide range of indications.
A mature and reliable clinical research hub with:
Outstanding recruitment performance
High compliance with ICH-GCP
Qualified English-speaking investigators
Consistent CRO success across multiple therapeutic areas
Georgia is widely recognised as one of the best performing small-population countries in Europe.
Together, the two countries offer:
Diverse patient pools
Lower competition for participants
Motivated investigators
Predictable regulatory pathways with quick approval timelines
Helixion ensures seamless operations across both markets.